We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$3.29B
AUM Growth
+$214M
Cap. Flow
+$117M
Cap. Flow %
3.56%
Top 10 Hldgs %
39.42%
Holding
1,306
New
253
Increased
442
Reduced
554
Closed
57

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$15.9M
2
NVDA icon
NVIDIA
NVDA
+$8.37M
3
TSLA icon
Tesla
TSLA
+$6.93M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.33M
5
STX icon
Seagate
STX
+$4.32M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$28.2M
2
AAPL icon
Apple
AAPL
+$5.8M
3
AMZN icon
Amazon
AMZN
+$4.35M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.97M
5
BABA icon
Alibaba
BABA
+$3.95M

Sector Composition

Rank Sector Weight
1 Technology 45.99%
2 Healthcare 11.64%
3 Communication Services 11.05%
4 Consumer Discretionary 10.25%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
176
Madrigal Pharmaceuticals
MDGL
$12.6B
$2.42M 0.07%
4,157
-45
-1% -$23K
PTCT icon
177
PTC Therapeutics
PTCT
$6.37B
$2.42M 0.07%
31,853
+9,591
+43% +$697K
SLB icon
178
SLB Ltd
SLB
$77.8B
$2.42M 0.07%
63,003
-8,114
-11% -$294K
KO icon
179
Coca-Cola
KO
$354B
$2.42M 0.07%
34,548
+1,022
+3% +$71.2K
BSX icon
180
Boston Scientific
BSX
$65.8B
$2.41M 0.07%
25,269
+4,542
+22% +$445K
TVTX icon
181
Travere Therapeutics
TVTX
$5.33B
$2.39M 0.07%
62,604
+42,366
+209% +$1.38M
SHW icon
182
Sherwin-Williams
SHW
$78.3B
$2.39M 0.07%
7,381
-570
-7% -$191K
MS icon
183
Morgan Stanley
MS
$337B
$2.38M 0.07%
13,418
-3,190
-19% -$532K
DHR icon
184
Danaher
DHR
$135B
$2.34M 0.07%
10,227
+1,998
+24% +$439K
PCVX icon
185
Vaxcyte
PCVX
$7.89B
$2.33M 0.07%
50,447
+17,525
+53% +$784K
VALE icon
186
Vale
VALE
$62.9B
$2.32M 0.07%
178,021
+16,962
+11% +$206K
C icon
187
Citigroup
C
$222B
$2.3M 0.07%
19,704
-5,739
-23% -$596K
MRNA icon
188
Moderna
MRNA
$21.5B
$2.3M 0.07%
77,896
+5,159
+7% +$140K
WMB icon
189
Williams Companies
WMB
$90.5B
$2.29M 0.07%
38,059
-7,078
-16% -$428K
RNAM
190
DELISTED
Avidity Biosciences
RNAM
$2.28M 0.07%
31,642
-6,012
-16% -$388K
NET icon
191
Cloudflare
NET
$93B
$2.26M 0.07%
11,477
-640
-5% -$135K
ALKS icon
192
Alkermes
ALKS
$8.82B
$2.26M 0.07%
80,624
+36,067
+81% +$1.08M
RYTM icon
193
Rhythm Pharmaceuticals
RYTM
$7B
$2.25M 0.07%
21,046
+8,589
+69% +$911K
RGLD icon
194
Royal Gold
RGLD
$17.1B
$2.25M 0.07%
10,132
+512
+5% +$102K
PAAS icon
195
Pan American Silver
PAAS
$18.6B
$2.25M 0.07%
43,354
-8,663
-17% -$363K
PTGX icon
196
Protagonist Therapeutics
PTGX
$8.75B
$2.23M 0.07%
25,574
+7,417
+41% +$607K
TGTX icon
197
TG Therapeutics
TGTX
$8.58B
$2.23M 0.07%
74,814
+24,569
+49% +$802K
NBIX icon
198
Neurocrine Biosciences
NBIX
$17.7B
$2.23M 0.07%
15,700
+1,631
+12% +$236K
INFY icon
199
Infosys
INFY
$45B
$2.21M 0.07%
123,841
-70
-0.1% -$1.21K
CDTX
200
DELISTED
Cidara Therapeutics
CDTX
$2.19M 0.07%
9,931
+3,156
+47% +$510K
6 7
8
9 10

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Profund Advisors held 1,306 positions worth $3.29B, up 7% from $3.08B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Profund Advisors deployed $117M of net new capital in Q4 2025, opening 253 new positions and adding to 442 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 58,342 shares worth $3.73M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 47% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Broadcom, an estimated $28.2M trimmed.

  • Profund Advisors's largest Q4 2025 buy was Ferrovial N.V. Ordinary Shares: 58,342 shares worth $3.73M.
  • Profund Advisors added most to Meta Platforms (Facebook) in Q4 2025, an estimated $15.9M increase.
  • Profund Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $28.2M.
  • Profund Advisors fully exited GlobalFoundries in Q4 2025, selling an estimated $1.63M.
  • Profund Advisors's ten largest holdings make up 39% of its $3.29B portfolio in Q4 2025.
  • Profund Advisors opened 253 new positions and closed 57 in Q4 2025.
  • Profund Advisors's portfolio value rose 7% quarter-over-quarter to $3.29B.

Based on Profund Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.